Skip to main content

Point72 Asset Management, L.P.

Position in ORGO — Organogenesis Holdings Inc.

CIK 1603466 STAMFORD, CT

Position in ORGO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$351,608
-$1,664,686 QoQ
Shares Held
148,358
-61.9% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ORGO Over Time

Shares Held

Position Value (USD)

Derivatives in ORGO

reported options exposure · as of Sep 30, 2023
CallValue
$143,100
CallShares
45,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ORGO

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $351,608 148,358
2025-12-31 $2,016,294 389,246
2023-09-30 $1,351,500 425,000
2023-09-30 $143,100 45,000
2023-06-30 $19,601 5,904
2023-03-31 $145,545 68,331